Point72 Asset Management’s Provention Bio PRVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-2,377
Closed -$57.3K – 2958
2023
Q1
$57.3K Buy
+2,377
New +$29.8K ﹤0.01% 1758
2019
Q2
– Sell
-56,751
Closed -$131K – 1607
2019
Q1
$131K Hold
56,751
– – ﹤0.01% 943
2018
Q4
$100K Buy
+56,751
New +$163K ﹤0.01% 909

Other funds holding PRVB

Point72 Asset Management's PRVB Position: Q2 2023 in Review

Point72 Asset Management sold out of Provention Bio (PRVB) in Q2 2023, closing a stake of 2,377 shares — an estimated $57.3K sold.

Point72 Asset Management first reported a position in PRVB in Q4 2018 and held it in 3 quarters. The position peaked at $131K in Q1 2019. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

  • Point72 Asset Management reported no remaining Provention Bio position as of Q2 2023 after selling out during the quarter.
  • Point72 Asset Management sold 2,377 Provention Bio shares in Q2 2023, an estimated $57.3K.
  • Point72 Asset Management first reported a position in Provention Bio in Q4 2018 and held it in 3 quarters.
  • Point72 Asset Management's Provention Bio position peaked at $131K in Q1 2019.
  • 1 fund tracked by Wall St. Rank held Provention Bio as of Q2 2023.

Based on Point72 Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.